These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7487373)

  • 1. Effect of macrophage-modulating agents on in vivo growth of transplantable Lewis lung cancer in mice.
    Nowicki A; Ostrowska G; Aukerman SL; Wiktor-Jedrzejczak W
    Arch Immunol Ther Exp (Warsz); 1994; 42(4):313-7. PubMed ID: 7487373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of purified recombinant human macrophage colony-stimulating factor in combination with local hyperthermia on tumor progression in B16a melanoma bearing mice.
    Lu L; Xiao M; Wu B; Wang WX; Yan WR; Broxmeyer HE; Shen RN
    Int J Hematol; 1993 Oct; 58(3):139-52. PubMed ID: 8148492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of recombinant human interleukin 6, alone or in combination with local irradiation, on tumor growth in Lewis lung carcinoma-bearing mice.
    Lu L; Shen RN; Broxmeyer HE
    Int J Cell Cloning; 1991 Sep; 9(5):511-20. PubMed ID: 1955739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
    Vallera DA; Taylor PA; Aukerman SL; Blazar BR
    Cancer Res; 1993 Sep; 53(18):4273-80. PubMed ID: 8364923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice.
    Maestroni GJ; Covacci V; Conti A
    Cancer Res; 1994 May; 54(9):2429-32. PubMed ID: 8162592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic effect of vaccinia virus secreting granulocyte-macrophage colony-stimulating factor on pulmonary metastatic melanoma].
    Ju D; Cao X; Ma S
    Zhonghua Zhong Liu Za Zhi; 1996 May; 18(3):165-8. PubMed ID: 9387245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal scheduling of interleukin-12 and fractionated radiation therapy in the murine Lewis lung carcinoma.
    Teicher BA; Ara G; Buxton D; Leonard J; Schaub RG
    Radiat Oncol Investig; 1998; 6(2):71-80. PubMed ID: 9572683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X; Huang X; Ju DW; Zhang W; Hamada H; Wang J
    Cancer Gene Ther; 2000 Feb; 7(2):177-86. PubMed ID: 10770625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-immunogenic murine hepatocellular carcinoma Hepa1-6 cells expressing the membrane form of macrophage colony stimulating factor are rejected in vivo and lead to CD8+ T-cell immunity against the parental tumor.
    Dan Q; Sanchez R; Delgado C; Wepsic HT; Morgan K; Chen Y; Jeffes EW; Lowell CA; Morgan TR; Jadus MR
    Mol Ther; 2001 Nov; 4(5):427-37. PubMed ID: 11708879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of recombinant macrophage colony-stimulating factor and recombinant gamma-interferon: toxicity, monocytosis, and clinical effects.
    Weiner LM; Li W; Holmes M; Catalano RB; Dovnarsky M; Padavic K; Alpaugh RK
    Cancer Res; 1994 Aug; 54(15):4084-90. PubMed ID: 8033141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK
    Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF, and IL-1 beta following acute endotoxemia.
    Feder LS; Laskin DL
    J Leukoc Biol; 1994 Apr; 55(4):507-13. PubMed ID: 8145021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
    Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
    Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.
    Aharinejad S; Paulus P; Sioud M; Hofmann M; Zins K; Schäfer R; Stanley ER; Abraham D
    Cancer Res; 2004 Aug; 64(15):5378-84. PubMed ID: 15289345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage colony-stimulating factor inhibits tumor necrosis factor production and prolongs skin graft survival.
    Nishina T; Naomoto Y; Gouchi A; Gunduz M; Shirakawa Y; Nobuhisa T; Motoki T; Kusaka S; Haisa M; Matsuoka J; Nakayama E; Tanaka N
    Transplantation; 2004 Feb; 77(3):456-59. PubMed ID: 14966426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
    Kimura Y; Taniguchi M; Baba K
    Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic humoral factor-gamma 2 augments immune cell response and exerts antitumor activity in murine model systems.
    Beuth J; Schierholz JM; Mayer G; Keisari Y
    Anticancer Res; 2000; 20(6B):4473-6. PubMed ID: 11205290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway.
    Zins K; Abraham D; Sioud M; Aharinejad S
    Cancer Res; 2007 Feb; 67(3):1038-45. PubMed ID: 17283136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.